Similar Articles
321 Recent progress in understanding mitokines as diagnostic and therapeutic targets in hepatocellular carcinoma
322 Hemocholecyst caused by accidental injury associated with radiofrequency ablation for hepatocellular carcinoma: A case report
323 Prognostic role of metformin in diabetes mellitus type 2 patients with hepatocellular carcinoma: A systematic review and meta-analysis
324 Physcion increases the sensitivity of hepatocellular carcinoma to sorafenib through miRNA-370/PIM1 axis-regulated glycolysis
325 Expression patterns of cluster of differentiation 147 impact the prognosis of hepatocellular carcinoma
326 Development and application of hepatocellular carcinoma risk prediction model based on clinical characteristics and liver related indexes
327 MiR-204-3p overexpression inhibits gastric carcinoma cell proliferation by inhibiting the MAPK pathway and RIP1/MLK1 necroptosis pathway to promote apoptosis
328 Liver transplantation for combined hepatocellular carcinoma and cholangiocarcinoma: A multicenter study
329 Serum resistin and the risk for hepatocellular carcinoma in diabetic patients
330 Radiomics model based on contrast-enhanced computed tomography to predict early recurrence in patients with hepatocellular carcinoma after radical resection
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA